EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Analyzing real-world adverse events of spironolactone with the FAERS database

Guowei Lin iD, Ru Chen, Chaoning Wen, Zhuopin Li, Xiangshan Yan, Lixian Li

PLOS One · 2025

DOI: 10.1371/journal.pone.0330659 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Guowei Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Putian University Affiliated Hospital, Putian, Fujian, China. Hauptthemen laut MEDLINE: Spironolactone, Adverse Drug Reaction Reporting Systems, Drug-Related Side Effects and Adverse Reactions, Diuretics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Spironolactone, a potassium-sparing diuretic, is commonly prescribed for conditions such as heart failure, hypertension, and hyperaldosteronism. This study aims to explore and analyze the safety profile of spironolactone by examining adverse event reports from the FDA Adverse Event Reporting System (FAERS) database.

Methods

This study conducted a retrospective pharmacovigilance analysis using FAERS data (2004 Q1–2024 Q3). Adverse drug events (ADEs) related to spironolactone were identified and categorized by system organ class and specific adverse events. Statistical methods such as Proportional Reporting Ratio (PRR), Reporting Odds Ratio (ROR), Bayesian Confidence Propagation Neural Network (BCPNN), and Empirical Bayesian Geometric Mean (EBGM) were employed to detect potential safety signals.

Results

A total of 8,566 ADE reports were associated with spironolactone, with 2409 preferred terms and 25 system organ classes showing significant disproportionality. Notable rare ADEs identified included endometriosis male (n = 7; ROR 13615.84), 5-alpha-reductase deficiency (n = 5; ROR 1620.81), bulbospinal muscular atrophy congenital (n = 6; ROR 402.42) and double-hit lymphoma (n = 5; ROR 243.12).

Conclusion

While most findings were consistent with spironolactone’s known effects, new signals, including a potential link to male endometriosis in high-risk groups, were identified. Further research is needed to confirm these findings and improve long-term safety assessment and clinical management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SpironolactoneAdverse Drug Reaction Reporting SystemsDrug-Related Side Effects and Adverse ReactionsDiureticsHumansMaleFemaleRetrospective StudiesPharmacovigilanceDatabases, FactualMiddle AgedAdultUnited StatesBayes TheoremAgedAdolescentUnited States Food and Drug AdministrationYoung Adult

Substanzen

SpironolactoneDiuretics

Autor:innen und Institutionen

  • Department of Urology, Putian University Affiliated Hospital, Putian, Fujian, China.
  • Department of Urology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.

ORCID-Profile: Guowei Lin

Zitieren

APA

Lin, G., Chen, R., Wen, C., Li, Z., Yan, X., & Li, L. (2025). Analyzing real-world adverse events of spironolactone with the FAERS database. PLOS One. https://doi.org/10.1371/journal.pone.0330659

Vancouver

Lin G, Chen R, Wen C, Li Z, Yan X, Li L. Analyzing real-world adverse events of spironolactone with the FAERS database. PLOS One. 2025. doi:10.1371/journal.pone.0330659

BibTeX
@article{Lin2025,
  author = {Lin, Guowei and Chen, Ru and Wen, Chaoning and Li, Zhuopin and Yan, Xiangshan and Li, Lixian},
  title = {Analyzing real-world adverse events of spironolactone with the FAERS database},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0330659}
}
Kostenlos starten →